Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Aug 31, 2025 | (FY)May 31, 2025 | (Q4)May 31, 2025 | (Q3)Feb 28, 2025 | (Q2)Nov 30, 2024 | (Q1)Aug 31, 2024 | (FY)May 31, 2024 | (Q4)May 31, 2024 | (Q3)Feb 29, 2024 | (Q2)Nov 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 7.80%9.22M | 6.17%33.38M | 9.40%8.48M | 4.97%8.23M | 1.46%8.12M | 8.98%8.55M | 2.87%31.44M | 0.47%7.75M | 5.94%7.84M | -1.34%8M |
| Cost of revenue | 2.69%6.04M | -9.09%22.99M | -10.00%5.91M | -5.85%5.8M | -15.40%5.41M | -4.82%5.88M | 8.93%25.29M | 6.73%6.57M | 11.18%6.16M | 8.73%6.39M |
| Gross profit | 19.09%3.18M | 68.93%10.39M | 116.86%2.57M | 44.40%2.44M | 68.34%2.71M | 60.22%2.67M | -16.28%6.15M | -24.17%1.19M | -9.58%1.69M | -27.85%1.61M |
| Operating expense | -14.41%1.63M | 21.22%6.91M | -41.88%2.13M | 6.01%1.85M | 11.84%1.97M | 26.34%1.91M | 4.87%5.7M | 8,856.10%3.67M | 17.81%1.75M | -23.49%1.77M |
| Selling and administrative expenses | -8.16%1.63M | 17.64%7.87M | 27.08%2.12M | 6.19%1.85M | 10.22%1.94M | 17.67%1.78M | -22.31%6.69M | -48.20%1.67M | 18.61%1.75M | -23.62%1.76M |
| -General and administrative expense | -8.16%1.63M | 17.64%7.87M | 27.08%2.12M | 6.19%1.85M | 10.22%1.94M | 17.67%1.78M | -22.31%6.69M | -48.20%1.67M | 18.61%1.75M | -23.62%1.76M |
| Other operating expenses | -99.24%1K | -91.38%173K | -99.35%13K | ---- | 966.67%32K | --131K | --2.01M | --2M | ---- | --3K |
| Total other operating income | ---- | -3.05%955K | ---- | --3K | ---- | ---- | -68.94%985K | ---- | --0 | ---- |
| Operating profit | 103.57%1.54M | 677.63%3.48M | 117.62%438K | 1,131.58%588K | 579.22%738K | 394.77%757K | -76.57%447K | -263.23%-2.49M | -114.77%-57K | -108.11%-154K |
| Net non-operating interest income (expenses) | -801.28%-703K | -529.97%-1.87M | -627.38%-611K | -829.69%-595K | -726.76%-587K | 0.00%-78K | 31.25%-297K | 18.45%-84K | 28.89%-64K | 37.72%-71K |
| Non-operating interest expense | 801.28%703K | 529.97%1.87M | 627.38%611K | 829.69%595K | 726.76%587K | 0.00%78K | -31.25%297K | -18.45%84K | -28.89%64K | -37.72%71K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 122.08%443K | -680.54%-2.01M | ||||||||
| Less:Write off | ---- | -122.08%-443K | ---- | ---- | ---- | ---- | 680.54%2.01M | ---- | ---- | ---- |
| Other non-operating income (expenses) | -53.91%118K | 41.93%1.4M | 224.52%675K | 10.80%195K | -22.73%272K | 2.81%256K | 985K | 208K | -36.46%176K | -13.51%352K |
| Income before tax | 2.25%956K | 210.34%2.05M | 121.25%502K | 241.82%188K | 233.07%423K | 188.58%935K | -252.26%-1.86M | -1,041.04%-2.36M | -90.40%55K | -42.01%127K |
| Income tax | 17.45%377K | 23.48%1.34M | -41.58%295K | 126.90%329K | 93.17%396K | 38.96%321K | 51.46%1.09M | 4,308.33%505K | -11.04%145K | -37.69%205K |
| Net income | -5.70%579K | 124.03%707K | 107.22%207K | -56.67%-141K | 134.62%27K | 560.22%614K | -686.06%-2.94M | -1,190.11%-2.87M | -121.95%-90K | 29.09%-78K |
| Net income continuous operations | -5.70%579K | 124.03%707K | 107.22%207K | -56.67%-141K | 134.62%27K | 560.22%614K | -686.06%-2.94M | -1,190.11%-2.87M | -121.95%-90K | 29.09%-78K |
| Noncontrolling interests | -18.04%527K | 113.64%1.71M | 454.55%244K | 61.85%437K | 94.42%383K | 123.26%643K | -9.92%799K | -62.07%44K | -10.60%270K | -40.48%197K |
| Net income attributable to the company | 279.31%52K | 73.27%-1M | 98.73%-37K | -60.56%-578K | -29.45%-356K | 85.13%-29K | -871.69%-3.74M | -2,080.27%-2.91M | -433.33%-360K | 37.64%-275K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 279.31%52K | 73.27%-1M | 98.73%-37K | -60.56%-578K | -29.45%-356K | 85.13%-29K | -871.69%-3.74M | -2,080.27%-2.91M | -433.33%-360K | 37.64%-275K |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 200.00%0.0001 | 73.42%-0.0021 | 98.39%-0.0001 | -50.00%-0.0012 | -33.33%-0.0008 | 75.00%-0.0001 | -887.50%-0.0079 | -2,166.67%-0.0062 | -500.00%-0.0008 | 33.33%-0.0006 |
| Diluted earnings per share | 200.00%0.0001 | 73.42%-0.0021 | 98.39%-0.0001 | -50.00%-0.0012 | -33.33%-0.0008 | 75.00%-0.0001 | -887.50%-0.0079 | -2,166.67%-0.0062 | -500.00%-0.0008 | 33.33%-0.0006 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.